Literature DB >> 28789409

MicroRNA-20a contributes to cisplatin-resistance and migration of OVCAR3 ovarian cancer cell line.

Yankun Liu1, Sugui Han2, Yuhui Li3, Yan Liu4, Di Zhang1, Yufeng Li1, Jinghua Zhang1.   

Abstract

MicroRNAs (miRs) have been reported to be associated with the development of numerous types of cancer. However, the function of miRs in human ovarian carcinoma chemoresistance remains largely undefined. In the present study, cell chemotherapy combined with a Cell Counting Kit-8 assay demonstrated that miR-20a performed important roles in ovarian cancer cells chemoresistance. Flow cytometry, cellular proliferation assays and Transwell assays results revealed that the proliferation and migration rates of OVCAR3/DDP cells were increased in comparison with parental cells. Western blot analysis results suggested that epithelial-mesenchymal transition (EMT) activated by miR-20a contributed to OVCAR3/DDP cell migration. The present study highlighted the importance of miR-20a in regulating the chemoresistant properties of OVCAR3 cells and promoting cisplatin-resistant cell migration by activating EMT. The results of present study may therefore provide novel insights into reversing the chemoresistance of ovarian cancer and improving its treatment.

Entities:  

Keywords:  cisplatin; microRNA-20a; migration; ovarian cancer; resistance

Year:  2017        PMID: 28789409      PMCID: PMC5529943          DOI: 10.3892/ol.2017.6348

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  32 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  N Colombo; M Peiretti; G Parma; M Lapresa; R Mancari; S Carinelli; C Sessa; M Castiglione
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

Review 3.  Current standards of care for chemotherapy of optimally cytoreduced advanced epithelial ovarian cancer.

Authors:  Maurie Markman
Journal:  Gynecol Oncol       Date:  2013-05-30       Impact factor: 5.482

Review 4.  MicroRNAs: small RNAs with big effects.

Authors:  Dany Anglicheau; Thangamani Muthukumar; Manikkam Suthanthiran
Journal:  Transplantation       Date:  2010-07-27       Impact factor: 4.939

5.  miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1.

Authors:  Junjie Yu; Youyi Lu; Di Cui; Enhui Li; Yipin Zhu; Yuyang Zhao; Fujun Zhao; Shujie Xia
Journal:  Oncol Rep       Date:  2013-12-05       Impact factor: 3.906

6.  Over-expression of miR-31 or loss of KCNMA1 leads to increased cisplatin resistance in ovarian cancer cells.

Authors:  Priya Samuel; Ryan Charles Pink; Daniel Paul Caley; James Michael Stevenson Currie; Susan Ann Brooks; David Raul Francisco Carter
Journal:  Tumour Biol       Date:  2015-09-19

7.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

Review 8.  Metastasis: new perspectives on an old problem.

Authors:  Sandra Kraljevic Pavelic; Mirela Sedic; Hrvojka Bosnjak; Sime Spaventi; Kresimir Pavelic
Journal:  Mol Cancer       Date:  2011-02-22       Impact factor: 27.401

9.  Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer.

Authors:  Jixiao Niu; Aimin Xue; Yayun Chi; Jingyan Xue; Wei Wang; Ziqin Zhao; Meiyun Fan; Chuan He Yang; Zhi-Ming Shao; Lawrence M Pfeffer; Jiong Wu; Zhao-Hui Wu
Journal:  Oncogene       Date:  2015-06-01       Impact factor: 9.867

Review 10.  Role of microRNAs in the resistance of prostate cancer to docetaxel and paclitaxel.

Authors:  Ewa Kopczyńska
Journal:  Contemp Oncol (Pozn)       Date:  2016-01-13
View more
  8 in total

1.  Ovarian Cancer Stem Cells: Characterization and Role in Tumorigenesis.

Authors:  Sarama Saha; Seema Parte; Partha Roy; Sham S Kakar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Kiavash Hushmandi; Mahshad Kalantari; Reza Mohammadinejad; Tahereh Javaheri; Gautam Sethi
Journal:  Int J Mol Sci       Date:  2020-06-03       Impact factor: 5.923

3.  MiR-20a, a novel promising biomarker to predict prognosis in human cancer: a meta-analysis.

Authors:  Donghua Huang; Yizhong Peng; Kaige Ma; Xiangyu Deng; Lu Tang; Doudou Jing; Zengwu Shao
Journal:  BMC Cancer       Date:  2018-11-29       Impact factor: 4.430

4.  Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study.

Authors:  Martina Morini; Davide Cangelosi; Daniela Segalerba; Danilo Marimpietri; Federica Raggi; Aurora Castellano; Doriana Fruci; Jaime Font de Mora; Adela Cañete; Yania Yáñez; Virginie Viprey; Maria Valeria Corrias; Barbara Carlini; Annalisa Pezzolo; Gudrun Schleiermacher; Katia Mazzocco; Ruth Ladenstein; Angela Rita Sementa; Massimo Conte; Alberto Garaventa; Susan Burchill; Roberto Luksch; Maria Carla Bosco; Alessandra Eva; Luigi Varesio
Journal:  Cancers (Basel)       Date:  2019-09-30       Impact factor: 6.639

5.  Exosomal‑miR‑10a derived from colorectal cancer cells suppresses migration of human lung fibroblasts, and expression of IL‑6, IL‑8 and IL‑1β.

Authors:  Jian Wang; Yuanting Liu; Ying Li; Xuan Zheng; Jianhui Gan; Zhaoyuan Wan; Jun Zhang; Yan Liu; Yaqi Wang; Wanning Hu; Yufeng Li; Yankun Liu
Journal:  Mol Med Rep       Date:  2020-11-25       Impact factor: 2.952

6.  Investigation of role of CpG methylation in some epithelial mesenchymal transition gene in a chemoresistant ovarian cancer cell line.

Authors:  Yaman Alghamian; Chadi Soukkarieh; Abdul Qader Abbady; Hossam Murad
Journal:  Sci Rep       Date:  2022-05-06       Impact factor: 4.996

Review 7.  Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine.

Authors:  Amoolya Kandettu; Divya Adiga; Vasudha Devi; Padmanaban S Suresh; Sanjiban Chakrabarty; Raghu Radhakrishnan; Shama Prasada Kabekkodu
Journal:  Genes Dis       Date:  2022-03-01

Review 8.  Small Non-Coding-RNA in Gynecological Malignancies.

Authors:  Shailendra Kumar Dhar Dwivedi; Geeta Rao; Anindya Dey; Priyabrata Mukherjee; Jonathan D Wren; Resham Bhattacharya
Journal:  Cancers (Basel)       Date:  2021-03-03       Impact factor: 6.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.